Trombo embolismo pulmonar y hepatitis toxica fulminante en la persona transexual (página 2)
18. Moller S, Iversen P y
Franzmann M B: F l u t a m i d e -induced liver failure. J
Hepatol 1990; 10: 346-9.
19. Moller S, Iversen P, Franzmann
MB. Flutamide-induced liver failure. J Hepatol 1990; 10:
346.
20. Navarro VJ, Senior JR.
Drug-related hepatotoxicity. N Engl J Med 2006; 354:
731-739.
21. Okaneya T, Murata Y, Kinebuchi
Y. Fatal hepatic failure following hepatitis caused by
flutamide: a case report. Nippon Hinyo kika Gakkai Zasshi
1999; 90: 590-3.
22. Pontiroli L, Sartori M, Pittau
S, Morelli S, Boldorini R, Albano E. Flutamide-induced acute
hepatitis: investigation on the role of immunoallergic
mechanisms. Ital J Gastroenterol Hepatol 1998; 30:
310-4.
23. Prattichizzo F A: Acute
cholestatic hepatitis secondary to flutamide therapy. Am J
Med 1994; 96: 3 9 2 – 3.
24. Pu YS, Liu CM, Kao JH, Chen J,
Lai MK. Antiandrogen hepatotoxicity in patients with chronic
viral hepatitis. Eur Urol 1999; 36: 293-297.
25. Rodríguez Gómez
SJ, Martínez Moreno J, Martín Arribas MI,
Pérez Villoria A, De la Serna Higuera C, Betancourt
González A. Fallo hepático fulminante inducido
por flutamida. Rev Esp Enferm Dig 2000; 92: 411.
26. Rosenthal SA, Linstadt DE,
Leibenhaut MH, Andras EJ, Brooks CP, Stickney DR, et al.
Flutamide associated liver toxicity during treatment with
total androgen suppression and radiation therapy for prostate
cancer. Radiology 1996; 199: 451-455.
27. Rosman A S, Frissora-Rodeo C,
Marshall A T, Reiter B P y Paronetto F: Cholestatic hepatitis
following flutamide. Dig Dis Sci 1993; 38: 1756-9.
28. Sgro C, Clinard F, Ouazir K,
Chanay H, Allard C, Guilleminet C, et al. Incidence of
drug-induced hepatic injuries: A French population-based
study. Hepatology 2002; 36: 451-459.
29. Takashima E, Iguchi K, Usui S,
Yamamoto H, Hirano K. Metabolite Profiles of Flutamide in
Serum from Patients with Flutamide-Induced Hepatic
Dysfunction. Biol Pharm Bull 2003; 26(10):
1455-1460.
30. Wysowski D K, Freiman J P,
Tourtelot J B y Horton M L: Fatal and nonfatal hepatotoxicity
asso ciated with flutamide. Ann Intern Med 1993; 118: 8 6 0 –
4 .
31. Wysowski DK, Fourcroy JL.
Flutamide hepatotoxicity. J Urol 1996; 155:
209-214.
Referencias de hepatitis fulminante
por Ciproterona:
1. Blake JC, Sawyer AM, Dooley
JS.Severe hepatitis caused by cyproterone acetate. Gut 1990;
31: 556-7.2. Levesque H, Manchon ND, Moore
N, Blanckard CE Byar DP, Jordan WP.Fulminant hepatitis due to
cyproterone acetate. Lancet 1989; 1: 215-63. Wilson JD.Androgens. In:
Goodman A, Goodman L, Rall TW, Murad F. Goodman and Gilman.
The Pharmacological Basis of Therapeutics. 9ª ed. New
York: McGraw-Hill, 1996: 58: 1441-5
Referencias de
apoyo
1. Airhar t RA, Barnett TF,
Sullivan JW, Brinkman AO, Jenster G, Ris-Stalpers C.
Flutamide therapy for carcinoma of the prostate. South Med J
1978; 71: 798-8012. Akaza H, Usami M, Kotake T,
Koiso K, Aso Y. A randomized phase II trial of flutamide vs.
cholormadinone in previouly untreated prostatic cancer. The
Japan Futamide Study Group. Jpn J Clin Oncol 1993; 23:
178-85.3. Azziz R, Gay F. The treatment
of hyperandrogenic with oral contraceptives. Sem Reprod
Endocrinol 1989;7:246-544. Batukan C, Muderris II.
Efficacy of a new contraceptive containing drosperidone and
ethinyl estradiol in the long – term treatment of hirsutism.
Fertil Steril 2006;85: 436-40.5. Black M, Raucy J:
Acetaminophen, Alcohol and Cytochrome P450. Ann Intern Med
1986; 104:427-436.6. Blake JC, Sawyer AM, Dooley JS.
Severe hepatitis caused by cyproterone acetate. Gut 1990; 31:
556-7.7. Burton W lee, MD, Stephen I,
Stasior D, Etal. Embolismo pulmonar .8. Carson JL, Strom BL, Duff A, y
col: Safety of Nonsteroidal Anti-inflammatory drugs with
Respect to Acute Liver Disease. Arch Intern Med 1993;
153:1331-1335.9. Clínicas Médicas
de Norteamérica. Conceptos Actuales de Trombosis.
Tendencias Prevalecientes para el Diagnóstico y el
Tratamiento. McGraw-Hill Interamericana 1998. p.
445-476.10. Davidson BL, et als. Color
doppler ultrasound to detect proximal leg vein thrombosis.
Ann Inter Med 1992; 117: 735-8.11. Dawson L, Chow E, Morton G.
Fulminant hepatic failure associated with bicalutamide.
Urology 1997; 49: 283-412. Devoto E, Aravena L,
Ríos S. Tratamiento del hirsutismo con espironolactona
y con espironolactona más dexametasona. Rev Méd
Chile 2000;128:868- 75.13. Devoto E, Aravena L. Eficacia
de la flutamida en el tratamiento del hirsutismo.
Contribución del uso combinado con anticonceptivos
orales en mujeres Normo androgénicas. Rev Méd
Chile 2004;132:845-52.14. Dunn, N (2011 Apr 21).
«The risk of deep venous thrombosis with oral
contraceptives containing drospirenone.». BMJ (Clinical
research ed.) 342: pp. d 2519.15. Enzo Devoto C. Lucía
Aravena C. Actualizacion terapia del hirsutismo. Obst. Gin.
2006; 71(6): 425-431.16. Esparza R, Cabrera P,
Rodríguez F, Juliá G. Tromboembolismo pulmonar.
Manual de Neumología y Cirugía Torácica.
Madrid: Editores Médicos, S.A. 1.998:
1.027-58.17. Goldenberg SL, Bruchovsky N,
Rennie PS, Begman B, Damber JE, Tomic R. The combination of
cyproterone acetate and low dose dethylstelbestrol in the
treatment of advanced prostatic carcinoma. J Urol 1988; 140:
1460-5.18. Goldenberg SL, Bruchovsky N.
Use of cyproterone acetate in prostate cancer. Urol Clin
North Am 1991; 18: 111-2219. Goldzieher JW, Zamah NM, Oral
contraceptive side effects:1995 Dec; 52(6): 327-3520. Gonzalez A, Canga F, Cardenas
F, Castellano G, Garcia H, Cuenca B, et al. An unusual case
of hepatic adenoma in a male. Journal Clin. Gastroenterol.
1994; 19: 179-81.21. Gregoriou O, Bakas P,
Konidaris S, Papadias K, Mathiopoulos D, Creatsas G. The
effect of combined oral contraception with or without
spironolactone on bone mineral density of hyperandrogenaemic
women. Human Reproduction 1993; 8:1807-12.22. Gronhagen-riska c, hellstrom
pe, frose THB. Predisposing factors in hepatitis induced by
isoniazid- rifampin treatment of tuberculosis. Am. Rev.
Respir. Dis. 1978; 118: 461-23. Guidelines on diagnosis and
management of acute pulmonary embolism. European Heart
Journal 2000; 21: 1301-1336.24. Haid-Fischer F, Haid H.
Patología de las Enfermedades venosas, En:
Enfermedades de las Venas. Salvat Editores, Barcelona 1984:
33.25. Haimovici H. Cirugía
Vascular Principios y Técnicas., Salvat,
1986.26. Hammerstein J. Use of
cyproterone acetate in the treatment of acne, hirsutism and
virilism. J Steroid Biochem 1975;6:827-31. Breckwoldt M.
Side-effects and contraindications of treatment with
antiandrogens. Androgenization in women, in Hammerstein J,
Lachnit -Fixson U, Plewig G (Eds). Excerpta Médica
1980:266-75.27. Heit J, Silverstein M, Moliv
D, Et al . Predictors of survival after Deep vein Thrombosis
and Pulmonary embolism . A population Based cohort Study .
Arch. Intern. Med. 1999; 159:445-452.28. Helfer E, Miller JL, Rose LI.
Side – effects of spironolactone therapy in the hirsute
woman. J Clin Endocrinol Metab 1988;208-1129. Helfgott sm, sandberg-cook j,
zakim d, nestler J. Diclofenac-associated hepatotoxicity.
JAMA 1990; 264: 2660-2.30. Holmes L GW. Deep venous
thrombosis and pulmonary embolism: correlative evaluation and
therapeutic implications. Am J Roentgenol 1992; 159:
1149-55.31. Kassem NY, Neri RO, Munroe JS.
Effect of flutamide, an antiandrogen, on stage D cancer of
the prostate. Clin Pharmacol Ther 1981; 29: 256.32. Kerlin P, Davis GL, McGill DB,
Weiland LH, Adson MA, Sheedy PF 2nd. Hepatic adenoma and
focal nodular hyperplasia: clinical, pathologic, and
radiologic features. Gastroenterology 1983;84:
994-1002.33. Koch A, Bourger S, Ziegler S,
Dinkell H, Dawres JD, Victor N. Low molecular weight heparin
and unfractionated heparin in thrombosis prophylaxis after
major surgycal intervention. Update of previous meta analisis
(Review). British Journal of Surgery
1997;84(6):750-759.34. Labrie F. Mechanism of action
and pure antiandrogen properties of flutamide. Cancer
1993;72:3816-27.35. Larrey D, Pageaux GP: Genetic
Predisposition to Drug- Induced He-patotoxicity. J Hepatol
1997; 26: 12-19.36. Levesque H, Manchon ND, Moore
N, Blanckard CE, Byar DP, Jordan WP. Fulminant hepatitis due
to cyproterone acetate. Lancet 1989; 1: 215-6.37. Lewis jh. Drug-induced Liver
Disease. Med. Clin. North. Am. 2000; 84: 1275-311.38. Lily C. Lee MD, SM, Kaushal S.
Clinical manifestation of pulmonary embolism. Emergency
Medicine Clinics of North America 2001; 19 (4).39. Mackler MA, Liber ti JP, Smith
MJV. The effect of orchiectomy and various doses of
stilbestrol on plasma testosterone levels in patients with
carcinoma of the prostate.Invest Urol 1972; 9:
423-5.40. Makin A., Williams R.:
Acetaminophen overdose and acute liver failure: modern
management.1996 Yearbook of Intensive Care and Emergency
Medicine. J.L.Vincent (Edit.). Springer, Berlin
199641. Maria va, victorino rm.
Development and validation of a clinical for the diagnosis of
drug induced hepatitis. Hepatology 1997; 26:
664-9.42. Mayo R, Thurner J (1957). "La
causa de la ocurrencia predominante sinistral de la trombosis
de las venas pélvicas". Angiology 8 (5): 419–27.
PMID 13478912.43. Medicina Basada en la
Evidencia .Massachusetts General Hospital. Ed. Marban. Madrid
España, 1999. Capitulo : 11. Pags:
245-264.(IV).44. Moguilewsky M, Fiet J,
Tournemine C. Pharmacology of an antiandrogen, anandron, used
as an adjuvant therapy in the treatment of prostate cancer. J
Steroid Biochem 1986; 24:139-46.45. Monterrosa A. Anticonceptivos
orales combinados. Tercera edición. Bogotá:
Editorial Impresos Calidad; 200346. Moser KM, Rhodes PG, Hufnagel
CG. Chronic unilateral pulmonary artery thrombosis. N Engl. J
Med. 1965;272:1195-9.47. Muderris I I, Bayram F, Guven
M. A prospective, randomized trial comparing flutamide (250
mg/d) and finasteride (5 mg/d) in the treatment of hirsutism.
Fertil Steril 2000;73: 984-7.48. Nagorney A, Chen PN, Shin JS,
Lin XZ. Hepatic adenoma: an observation from asymptomatic
stage to rupture. Hepatogastroenterology 1996;
43:245-8.49. Nagorney DM. Benign hepatic
tumors: focal nodular hyperplasia and hepatocellular adenoma.
World Journal Surg. 1995; 19:13-18.50. Newton J. Classification and
comparison of oral contraceptives containing new generation
progestogens. Hum Reprod Update 1995; 1:231-63.51. Pepper G, Brenner SH,
Gabrielove JL. Ketoconazole use in the treatment of ovarian
hyperandrogenism. Fertil Steril 1990; 54: 438-44.52. Piccioli A, Prandoni P,
Goldhaber SZ. Epidemiologic characteristics, management, and
outcome of deep vein trombosis in a terapy care hospital: The
Brigham and Women!s Hospital DVT Registry. Am Heart J 1996;
132:1010 – 4.53. Pincus MR, Tierno P, Dufour
DR. Evaluation of liver function. In: McPherson RA, Pincus
MR, eds. Henry's Clinical Diagnosis and Management by
Laboratory Methods. 21st ed. Philadelphia, Pa: Saunders
Elsevier; 2006: chap 21.54. Pratt DS, Kaplan MM.
Evaluation of abnormal liver-enzyme results in asymptomatic
patients. N. Engl. J. Med. 2000; 342(17):
1266-127155. Reddy KR, Kligerman S, Levi J
et al. Benign and solid tumors of the liver: relationship to
sex, age, size of tumors, and outcome. Am. Surg. 2001;
67:173-178.56. Riordan S., Williams R.:
Treatment of hepatic encephalopathy. N. Engl. J. Med.
337:473-199757. Rittmaster RS. Treatment of
hirsutism. Endocrinologist 1993; 3: 211-8.58. Rocha E, Martínez F,
Monreal M (eds.). Manejo práctico y pautas de
actuación en la enfermedad tromboembólica
venosa. Madrid: Acción Médica 2004.59. Rooks JB, Ory WH, Ishak KG,
Strauss LT, Greenspan JR, Hill AP, et al. Epidemiology of
hepatocellular adenoma. The role of oral contraceptive use.
JAMA 1979;.242: 644-8.60. Rosenbaum P, Schmidt W,
Helmerhorst FM, Wutte W, Rossmanith W, Freundl F, et al.
Inhibition of ovulation by a novel progestogen (drospirenone)
alone or in combination with ethinylestradiol. Eur J
Contracept Reprod Health Care 2000;5:16-2461. Ryan KL, Fedullo PF, Davis GB,
Vázquez TE, Moser KM. Perfusion scans under stimate
the severity of angiographic and hemodynamic compromise in
chronic thrombo.embolic pulmonary hypertension. Chest 1988;
93:1180-5.62. Sáenz de la Calzada C,
et al . Guías de práctica clínica en
Trombo embolismo e hipertensión pulmonar. Revista
Española de Cardiologia 2001; 54(2):
194-210.63. Schellhammer P, Sharifi R,
Block N, Soloway M, Venner P, Patterson AL, et al. A
controlled trial of bicalutamide versus flutamide, each in
combination with luteinizing hormone-releasing hormone
analogue therapy in patients with advanced prostate cancer.
Urology 1995;.45:.7.45-52.64. Schiano td, lissos tw, ahmed
a, siano c, zaitman d, cohn g et al.
Lamivudine-stavudine-induced liver failure in hepatitis B
cirrhosis. Am. J. Gastroenterol. 1997; 92: 1563-4.65. Silverstein M, Heit J, Mohr D,
et al: Trends in the incidence of deep vein thrombosis and
pulmonary embolism: A 25-year population-based study. Arch
Intern Med 1998; 158:585-593.66. Simoncini T, Fu XD, Caruso A,
et al. Drospirenone increases endothelial nitric oxide
synthesis via a combined action on progesterone and
mineralocorticoid receptors. Hum Reprod 2007; 22:2325
-233467. Smikstein MJ, Knapp GL, Kulig
KW y col: Efficacy of Oral N-acetyl-cysteine in the Treatment
of Acetaminophen Overdose. Analysis of National Multicenter
Study (19761985).NEnglJMedl998;319: 1557-1562.68. Stricker bh, blok ap, claas
fh, vanparys ge, desmet vt. Hepatic injury associated with
the use of nitrofurantoin: A clinic pathological study of 52
reported cases. Hepatology 1988; 8: 599-606.69. Tapson VF, Carroll BA,
Davidson BL, Elliott CG, Fedullo PF, Hales CA, et al. The
diagnostic approach to acute venous thrombo embolism Clinical
practice guideline. American Thoracic Society. Am J Respir.
Crit. Care Med 1999; 160: 1043-66.70. Tela RM, Scott K. Evaluating
asymptomatic patients with abnormal liver functions tests
results. Am Fam Physician 1996; 53: 2111-2119.71. Udaya B. S. Prakash. Pulmonary
embolism. Mayo Clinic Cardiology Review. Murphy, Joseph G.
Segunda edic Capítulo 27. p. 379-406.72. Venturoli S, Marescalchi O,
Colombo F M, Macrelli S, Ravaioli M B, Bagnoli A, et al. A
prospective randomized trial comparing low dose flutamide,
finasteride, ketoconazole, and cyproterone acetate – estrogen
regimens in the treatment of hirsutism. J.73. Virchow, RLK Cellular
pathology as based upon physiological and pathohistology.
7th74. Vonberg PP. buller HA, Marsman
JWP. Hepatic artery ambolization: Succesfull treatment of
multinodular hemangiomatosis of the liver. Eur. J. Pediatr.
1986; 144:.472-74.75. Weimann A, Ringe B, Klempnauer
J et al. Benign liver tumors: differential diagnosis and
indications for surgery. World J. Surg. 1997;
21:983-99176. White WB, Pitt B, Preston RA,
et al. Antihypertensive effects of drospirenone with 17
beta-estradiol, a novel hormone treatment in postmenopausal
women with stage 1 hypertension. Circulation 2005;112 :1979
-1984.77. Wilson JD. Androgens. In:
Goodman A, Goodman L, Rall TW, Murad F. Goodman and Gilman.
The Pharmacological Basis of Therapeutics. 9ª ed. New
York: McGraw-Hill, 1996: 58: 1441-57.78. Wysowski DK, Fourcroy JL.
Flutamide hepatotoxicity. J Urol 1996;155:209-1279. Yamamoto T, Kawarada Y, Yano
T, Noguchi T. Mizumoto R. Spontaneus rupture of hemangioma of
the liver: Treatment with trans catheter hepatic arterial
embolization. Am. J. Gastroenterol. 1991;86:
1645-49.80. Young RL, Goldzieher JW,
Elkind – Hirsch K. The endocrine effects of spironolactone
used as an antiandrogen. Fertil Steril 1987;48:
223-8.81. Zimmerman hj, ishak kg.
General aspects of drug induced liver disease. Gastroenterol.
Clin. North Am. 1995; 248; 24: 739-57.82. Zimmerman HJ, Ishak KG.
General Aspects of Drug Induced Liver Disease. Gastroenterol.
Clin North Am 1995; 24: 739-755.
Autor:
Dra. Mireille Emmanuelle
Brambila
Higiene mental – Trastornos y enfermedades
somáticas
Mexicali Baja California. México
2013
 Página anterior | Volver al principio del trabajo | Página siguiente  |